In accordance with the goals of the EBMG our Professional Branch Board has opened the possibility for recognition of practitioners / non-Medical Doctors working in Human Genetics diagnostics laboratories to be recognized as European registered Clinical Laboratory Geneticists (ErCLG).

A core curriculum for the ErCLG was established in 2012 and was slightly revised in 2015 and 2022.

For the history of the Board see here.

All our actions will hopefully be EU-recognized in future based on the now approved EU Directive 2005/36/EC - policy developments  and Proposal for modernising the Professional Qualifications Directive = EU Directive 2013/55/EU. The latter was implemented on 16th January 2016. 
The request to EU has obviously to go to “Recognition Committee for Professional Qualification" from a EU memberstate national health ministry.

Interestingly there is also an OECD guideline for quality assurance in molecular genetic testing from 2007 in which following has been stated and requested - this document was approved by most if not all EU memberstates:

• E.3    Existing  specialist  education  and  training  programmes  relevant  to  molecular genetic testing that meet recognised standards should be formally adopted by governments, regulatory and/or professional bodies.
• E5.          Relevant  government  or  professional  authorities  should  recognise  medical  genetics  as  a  discipline  comprising  both  a  clinical  and  a  laboratory  specialty.
• E.ii           Appropriate    specialist    qualifications,    education    and    training    standards for individuals directing molecular genetics laboratories should be established. (...) Educational   requirements   should   include   formal   training   in   molecular  genetics   and   where   available,   certification   in   the   specialty   of   clinical   laboratory molecular genetics, or another relevant discipline. 
• E.vi    Comparison  of  specialist  education  and  training  systems  between  jurisdictions should be facilitated as a means to establish equivalence.
• 2. These   Guidelines   offer   principles   and   best   practices   for   quality   assurance  in  molecular  genetic  testing  for  clinical  purposes.  They  are  addressed to all those involved in the regulation and provision of molecular genetic  testing.  The  Guidelines  are  intended  to  assist  both  OECD  and  non-OECD  governments  in  the  development  and  introduction  of  their  standards  for  quality  assurance  systems  and  molecular  genetic  testing  laboratory  practices.  The  Guidelines  recognise  the  existence  of  regional,  national  and  international  quality  assurance  frameworks  and  seek  to  facilitate  their  mutual recognition.
• 24.  Principle  B2  refers  to  the  concept  of  “equivalent  recognition”.  This  should  include  assessment  of  competence  in  services  provided,  including  technical  competence  and  relevant  specialist  education  and  training;  and  also  compliance  with  relevant  legal,  professional  and  quality  management  standards. (B2)